Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

11:45 ET Three New Locations Added to Niagara County Pharmaceutical Drop-Box Program

 New York State Senator Rob Ortt, in a joint effort with the Niagara County Sheriff's Office, Niagara County Division of Environmental/Solid...


10:07 ET UMN Pharma Joins Protein Sciences' International Zika Vaccine Consortium

USA and Japan -- Protein Sciences Corporation, manufacturer of Flublok® influenza vaccine, and UMN Pharma Inc. (Akita, Akita prefecture,...


10:02 ET Indegene and IndigoMedical Form an Alliance to Provide Promotional/Medical Review and Approval Solutions for Biopharmaceutical Companies Across the Globe

Indegene (www.indegene.com), a leading global provider of clinical, commercial, and marketing solutions to life science, pharmaceutical, and...


09:56 ET Indegene and IndigoMedical Form an Alliance to Provide Promotional/Medical Review and Approval Solutions for Biopharmaceutical Companies Across the Globe

Indegene (www.indegene.com), a leading global provider of clinical, commercial, and marketing solutions to life science, pharmaceutical, and...


09:17 ET Showcase Days help growers resolve crop production challenges

 Growers around the country are invited to visit a local Showcase Days event and learn about the most recent advances in...


09:11 ET Kitov Pharmaceuticals Announces Pricing of $12 Million Follow-On Public Offering in the U.S.A.

 Kitov Pharmaceuticals (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company focused on late-stage drug development, today announced...


09:00 ET Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in San Antonio on July 8 and 9 for Qualified Healthcare Providers

 Braeburn Pharmaceuticals announces that healthcare provider training and certification for Probuphine will take place on July 8 and 9 in San...


09:00 ET World Infusion Devices Market 2016-2026

Forecasts for Insulin Pumps, Enteral Feeding Pumps, Other Infusion Pumps for Insulin Infusion, Drug Delivery, Oncology, Antibiotics, Analgesia,...


09:00 ET Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in New Orleans on July 8, 9 and 10 for Qualified Healthcare Providers

 Braeburn Pharmaceuticals announces that healthcare provider training and certification for Probuphine will take place on July 8, 9 and 10 in...


08:59 ET Express Scripts Announces Tender Offers for Outstanding Debt Securities

Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced that it has commenced tender offers to purchase...


08:28 ET Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Atlanta on July 8, 9 and 10 for Qualified Healthcare Providers

 Braeburn Pharmaceuticals announces that healthcare provider training and certification for Probuphine will take place on July 8, 9 and 10 in...


08:00 ET Iroko Pharmaceuticals Secures Debt Financing From CRG

 Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that...


08:00 ET Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Charleston on July 8, 9 and 10 for Qualified Healthcare Providers

 Braeburn Pharmaceuticals announces that healthcare provider training and certification for Probuphine will take place on July 8, 9 and 10 in...


08:00 ET Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Albany on July 8 and 9 for Qualified Healthcare Providers

 Braeburn Pharmaceuticals announces that healthcare provider training and certification for Probuphine will take place on July 8 and 9 in...


08:00 ET Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Grand Rapids on July 8 and 9 for Qualified Healthcare Providers

Braeburn Pharmaceuticals announces that healthcare provider training and certification for Probuphine will take place on July 8 and 9 in Grand...


08:00 ET BioPharmX Announces Positive Topline Phase 2a Clinical Trial Results for BPX-01 in Patients with Acne-Causing Bacteria

BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced topline...


08:00 ET Juniper Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference

 Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), announced today that George O. Elston, Chief Financial Officer,...


08:00 ET Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Orlando on July 8, 9 and 10 for Qualified Healthcare Providers

 Braeburn Pharmaceuticals announces that healthcare provider training and certification for Probuphine will take place on July 8, 9 and 10 in...


07:35 ET Ibrutinib (IMBRUVICA®) Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for the Development of a Treatment for Chronic Graft-Versus-Host Disease (cGVHD)

The U.S. Food and Drug Administration (FDA) has granted a fourth Breakthrough Therapy Designation (BTD) for ibrutinib (IMBRUVICA®): as...


07:00 ET Enterome to Participate at the Microbiome Drug Development Summit 2016 and the Festival of Genomics in Boston, USA

ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announces that Pierre...


07:00 ET Shire Announces Positive Topline Results of SHP465 Efficacy and Safety Study in Adults With ADHD

- Topline results revealed the study met its primary endpoints for both doses of SHP465 (12.5mg and 37.5mg) administered once daily,...


07:00 ET Center Point Clinical Services Signs Partnership Agreement with ContraVir Pharmaceuticals

Center Point Clinical Services, provider of specialty clinical research solutions including the signature Clinical Trials Research Pharmacist...


07:00 ET UMN, Minnesota cancer experts, community members partner to put an end to cancer

 The Masonic Cancer Center and University of Minnesota Health co-host the Minnesota Cancer Moonshot Summit today, supporting Vice President Joe...


07:00 ET EnteroMedics Highlights Recent Patient Success with vBloc® Therapy in Combination with vBloc® Achieve Program

EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other...